183 related articles for article (PubMed ID: 33105671)
1. Discovery and Evaluation of Enantiopure 9
Andreev S; Pantsar T; El-Gokha A; Ansideri F; Kudolo M; Anton DB; Sita G; Romasco J; Geibel C; Lämmerhofer M; Goettert MI; Tarozzi A; Laufer SA; Koch P
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105671
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of 7-Chloro-9
Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
[TBL] [Abstract][Full Text] [Related]
3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
4. Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors.
Andreev S; Pantsar T; Tesch R; Kahlke N; El-Gokha A; Ansideri F; Grätz L; Romasco J; Sita G; Geibel C; Lämmerhofer M; Tarozzi A; Knapp S; Laufer SA; Koch P
J Med Chem; 2022 Jan; 65(2):1283-1301. PubMed ID: 34213342
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analogues.
Han S; Zhou W; Zhuang C; Chen F
Bioorg Chem; 2022 Feb; 119():105537. PubMed ID: 34902644
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new GSK-3β inhibitors through structure-based virtual screening.
Dou X; Jiang L; Wang Y; Jin H; Liu Z; Zhang L
Bioorg Med Chem Lett; 2018 Jan; 28(2):160-166. PubMed ID: 29208522
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.
Yang Z; Liu H; Pan B; He F; Pan Z
Org Biomol Chem; 2018 Jun; 16(22):4127-4140. PubMed ID: 29781013
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.
Kohara T; Nakayama K; Watanabe K; Kusaka SI; Sakai D; Tanaka H; Fukunaga K; Sunada S; Nabeno M; Saito KI; Eguchi JI; Mori A; Tanaka S; Bessho T; Takiguchi-Hayashi K; Horikawa T
Bioorg Med Chem Lett; 2017 Aug; 27(16):3733-3738. PubMed ID: 28712706
[TBL] [Abstract][Full Text] [Related]
10. Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
Hulcová D; Breiterová K; Siatka T; Klímová K; Davani L; Šafratová M; Hošťálková A; De Simone A; Andrisano V; Cahlíková L
Molecules; 2018 Mar; 23(4):. PubMed ID: 29561817
[TBL] [Abstract][Full Text] [Related]
11. Identifying potential Alzheimer's disease therapeutics through GSK-3β inhibition: A molecular docking and dynamics approach.
Mohammadi Y; Emadi R; Maddahi A; Shirdel S; Morowvat MH
Comput Biol Chem; 2024 Aug; 111():108095. PubMed ID: 38805865
[TBL] [Abstract][Full Text] [Related]
12. A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.
Redenti S; Marcovich I; De Vita T; Pérez C; De Zorzi R; Demitri N; Perez DI; Bottegoni G; Bisignano P; Bissaro M; Moro S; Martinez A; Storici P; Spalluto G; Cavalli A; Federico S
ChemMedChem; 2019 Feb; 14(3):310-314. PubMed ID: 30548443
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
[TBL] [Abstract][Full Text] [Related]
14. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors.
Zhou Y; Zhang L; Fu X; Jiang Z; Tong R; Shi J; Li J; Zhong L
Chem Biodivers; 2019 Sep; 16(9):e1900304. PubMed ID: 31338947
[TBL] [Abstract][Full Text] [Related]
16. Discovery of thiazolidin-4-one analogue as selective GSK-3β inhibitor through structure based virtual screening.
Choudhary BS; Sukanya ; Mehta P; Bach S; Ruchaud S; Robert T; Josselin B; Filipek S; Malik R
Bioorg Med Chem Lett; 2021 Nov; 52():128375. PubMed ID: 34560262
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 4,5-bisindolyl-1,2,4-triazol-3-ones as glycogen synthase kinase-3β inhibitors and neuroprotective agents.
Hu Y; Ruan W; Gao A; Zhou Y; Gao L; Xu M; Gao J; Ye Q; Li J; Pang T
Pharmazie; 2017 Dec; 72(12):707-713. PubMed ID: 29441954
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3β inhibitors.
Arfeen M; Bhagat S; Patel R; Prasad S; Roy I; Chakraborti AK; Bharatam PV
Eur J Med Chem; 2016 Oct; 121():727-736. PubMed ID: 27423119
[TBL] [Abstract][Full Text] [Related]
19. First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.
Brogi S; Ramunno A; Savi L; Chemi G; Alfano G; Pecorelli A; Pambianchi E; Galatello P; Compagnoni G; Focher F; Biamonti G; Valacchi G; Butini S; Gemma S; Campiani G; Brindisi M
Eur J Med Chem; 2017 Sep; 138():438-457. PubMed ID: 28689095
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
Liang Z; Li QX
ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]